Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Metformin M/R tablets |
2nd line - only for patients intolerant of slowly titrated standard release metformin. Sukkarto SR 500mg and 1000mg. |
|
|
Methadone hydrochloride |
Palliative care only |
|
|
|
Methotrexate |
ILD - ESCA |
|
|
|
Methotrexate 2.5mg tablets |
Supported with an ESCA. Methotrexate tablets - use 2.5mg strength ONLY. Methotrexate injection - Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
|
Methotrexate injections |
Supported with an ESCA. Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
|
Methotrexate tablets (2.5mg) |
ESCA. Methotrexate tablets - use 2.5mg strength only. Methotrexate injection - Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
|
Methotrexate#13.5 |
ESCA |
|
|
Methotrexate#4.1 |
Specialist use only in neurological conditions |
|
|
|
Methoxy polyethelene glycol-epoetin beta (Mircera) |
NHSE commissioned renal dialysis. CCG commissioned for use in cancer - NICE TA323. |
|
|
|
Methoxyflurane (Penthrox®) |
For severe pain of traumatic origin and facilitation of management of significant fractures and dislocations |
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- Next page
- Last page
